These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 6722545

  • 1. Enkephalin inhibition of angiotensin-stimulated release of oxytocin and vasopressin.
    Keil LC, Rosella-Dampman LM, Emmert S, Chee O, Summy-Long JY.
    Brain Res; 1984 Apr 16; 297(2):329-36. PubMed ID: 6722545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cerebroventricular sites for enkephalin inhibition of the central actions of angiotensin.
    Summy-Long JY, Keil LC, Sells G, Kirby A, Chee O, Severs WB.
    Am J Physiol; 1983 Apr 16; 244(4):R522-9. PubMed ID: 6340533
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GABA agonists inhibit the vasopressin-dependent pressor effects of central angiotensin II.
    Brennan TJ, Morris M, Haywood JR.
    Neuroendocrinology; 1984 Nov 16; 39(5):429-36. PubMed ID: 6514131
    [Abstract] [Full Text] [Related]

  • 6. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
    Watanabe T, Oki Y, Orth DN.
    Endocrinology; 1989 Oct 16; 125(4):1921-31. PubMed ID: 2551632
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.
    Spinedi E, Negro-Vilar A.
    Neuroendocrinology; 1983 Dec 16; 37(6):446-53. PubMed ID: 6318148
    [Abstract] [Full Text] [Related]

  • 8. Endogenous opioid peptide inhibition of the central actions of angiotensin.
    Summy-Long JY, Keil LC, Deen K, Rosella L, Severs WB.
    J Pharmacol Exp Ther; 1981 Jun 16; 217(3):619-29. PubMed ID: 6262492
    [Abstract] [Full Text] [Related]

  • 9. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II.
    Aguilera G, Young WS, Kiss A, Bathia A.
    Neuroendocrinology; 1995 Apr 16; 61(4):437-44. PubMed ID: 7783857
    [Abstract] [Full Text] [Related]

  • 10. GABA inhibition of central angiotensin II and hypertonic CSF pressor responses.
    Brennan TJ, Haywood JR.
    Brain Res; 1983 May 16; 267(2):261-9. PubMed ID: 6871675
    [Abstract] [Full Text] [Related]

  • 11. A study on the release mechanism of vasopressin and oxytocin.
    Hashimoto H, Noto T, Nakajima T.
    Neuropeptides; 1988 May 16; 12(4):199-206. PubMed ID: 3237319
    [Abstract] [Full Text] [Related]

  • 12. Effects of chronic central infusion of oxytocin on the response of the magnocellular neuroendocrine system to osmotic stimulation.
    Koehler-Stec EM, Byers A, Summy-Long JY.
    Pharmacology; 1998 Feb 16; 56(2):101-10. PubMed ID: 9494068
    [Abstract] [Full Text] [Related]

  • 13. Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats.
    Kadekaro M, Terrell ML, Bui V, Summy-Long JY.
    Brain Res; 2001 Jan 19; 889(1-2):84-8. PubMed ID: 11166690
    [Abstract] [Full Text] [Related]

  • 14. Effect of chronic intracerebroventricular angiotensin II infusion on vasopressin release in rats.
    Sterling GH, Chee O, Riggs RV, Keil LC.
    Neuroendocrinology; 1980 Sep 19; 31(3):182-8. PubMed ID: 7413018
    [Abstract] [Full Text] [Related]

  • 15. Lack of response in the release of oxytocin and vasopressin from isolated neurohypophyses to dopamine, met-enkephalin and leu-enkephalin.
    Pitzel L, König A.
    Exp Brain Res; 1984 Sep 19; 56(2):221-6. PubMed ID: 6090193
    [Abstract] [Full Text] [Related]

  • 16. Role of NO on vasopressin and oxytocin release and blood pressure responses during osmotic stimulation in rats.
    Kadekaro M, Liu H, Terrell ML, Gestl S, Bui V, Summy-Long JY.
    Am J Physiol; 1997 Sep 19; 273(3 Pt 2):R1024-30. PubMed ID: 9321882
    [Abstract] [Full Text] [Related]

  • 17. Indomethacin prevents the L-NAME-induced increase in plasma levels of oxytocin in dehydrated rats.
    Kadekaro M, Terrell ML, Liu H, Bui V, Summy-Long JY.
    Brain Res; 2000 Sep 22; 877(2):371-3. PubMed ID: 10986353
    [Abstract] [Full Text] [Related]

  • 18. Vasopressin, fluid, and electrolyte response to chronic angiotensin II infusion.
    Cowley AW, Switzer SJ, Skelton MM.
    Am J Physiol; 1981 Mar 22; 240(3):R130-8. PubMed ID: 7212084
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II sensitive neurons in the supraoptic nucleus, subfornical organ and anteroventral third ventricle of rats in vitro.
    Okuya S, Inenaga K, Kaneko T, Yamashita H.
    Brain Res; 1987 Jan 27; 402(1):58-67. PubMed ID: 3030493
    [Abstract] [Full Text] [Related]

  • 20. Circulatory and osmoregulatory effects of angiotensin II perfusion of the third ventricle in a bird with salt glands.
    Gerstberger R, Gray DA, Simon E.
    J Physiol; 1984 Apr 27; 349():167-82. PubMed ID: 6737289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.